ClinConnect ClinConnect Logo
Search / Trial NCT05449002

Digital Single Session Intervention for Youth Mental Health

Launched by HARVARD UNIVERSITY · Jul 4, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at a new digital program designed to help young people who are experiencing anxiety, depression, conduct disorder, or stress. The program teaches participants a technique called "practicing the opposite," which encourages them to try different behaviors to improve their mental health. This study involves youth who are currently on a waiting list for traditional therapy, and it will compare the effects of this digital program to those who remain on the waitlist without any additional support.

To be eligible for this study, participants must be between the ages of 9 and 17 and have already reached out for mental health care at a participating clinic. They also need to be able to read English well enough to use the digital program and have access to a device like a tablet or a computer. If they decide to join, youth and at least one parent or guardian will need to agree to their participation. The trial is currently recruiting participants, so if you think this could be helpful, it’s a good opportunity to consider.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Youth/family has contacted a participating outpatient clinic to seek mental health care, and is placed on the waitlist.
  • Youth is between the ages of 9-17 years (inclusive) at the time of study enrollment.
  • Youth and at least one guardian consent to the youth's participation in study.
  • Youth reads English well enough to effectively complete the digital programs (defined as taking classes in English, as opposed to ESL classes).
  • Youth has access to a digital device.
  • Exclusion Criteria:
  • Youth is non-English speaking, as the program is only available in English.
  • Youth does not have access to a digital device.

About Harvard University

Harvard University, a prestigious Ivy League institution, is a leading sponsor of clinical trials, dedicated to advancing medical research and improving patient outcomes. With a strong emphasis on innovation and interdisciplinary collaboration, Harvard leverages its world-class faculty, cutting-edge facilities, and extensive resources to conduct rigorous clinical studies across various fields, including medicine, public health, and biomedical sciences. The university is committed to adhering to the highest ethical standards and regulatory guidelines, ensuring the safety and well-being of participants while contributing valuable insights to the global healthcare community. Through its clinical research initiatives, Harvard aims to translate scientific discoveries into effective treatments and preventive strategies that address pressing health challenges.

Locations

Boston, Massachusetts, United States

Indianapolis, Indiana, United States

Boston, Massachusetts, United States

Concord, Massachusetts, United States

Dedham, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

Katherine Venturo-Conerly, A.B.

Principal Investigator

Harvard University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials